Consultation by a Alabama licensed provider for a recommendation to the state program for:

• Autism Spectrum Disorder (ASD)
• Cancer-related cachexia, nausea or vomiting, weight loss, or chronic pain
• Crohn’s Disease
• Depression
• Epilepsy or a condition causing seizures
• HIV/AIDS-related nausea or weight loss
• Panic disorder
• Parkinson’s disease
• Persistent nausea that is not significantly responsive to traditional treatment, except for nausea related to pregnancy, cannabis-induced cyclical vomiting syndrome, or cannabinoid hyperemesis syndrome
• Post Traumatic Stress Disorder (PTSD)
• Sickle Cell Anemia
• Spasticity associated with a motor neuron disease, including Amyotrophic Lateral Sclerosis
• Spasticity associated with Multiple Sclerosis or a spinal cord injury
• Terminal illness
• Tourette’s Syndrome
• A condition causing chronic or intractable pain in which conventional therapeutic intervention and opiate therapy is contraindicated or has proved ineffective

* State law further requires recommending physicians to cite documentation indicating that “conventional medical treatment or therapy has failed” prior to issuing a medical cannabis recommendation.